Big Pharma Shuns Silver; Blackmails U.S. Government Into Paying for New Antibiotic Drugs With Taxpayer Money (July 18, 2012)

Big Pharma Shuns Silver; Blackmails U.S. Government Into Paying for New Antibiotic Drugs With Taxpayer Money

While numerous clinical studies have demonstrated the amazing effectiveness of colloidal silver and other forms of antimicrobial silver against drug-resistant pathogens, Big Pharma continues to ignore the evidence. Instead, they’re now forcing U.S. taxpayers to pay through the nose for the development of new classes of antibiotic drugs. And they’re lowering the safety testing requirements on those new drugs, which means they’ll be even more toxic and dangerous than ever. Here’s the story you won’t hear anywhere else…

Hi, Steve Barwick here, for The Silver Edge…

Back in December 2011 I wrote an article explaining that Big Pharma was essentially attempting to blackmail the U.S. government (as well as European governments) by threatening to stop all research into new antibiotic drugs…unless the government agrees to fund such new research with taxpayer money.

In other words, the big drug companies – which collectively make hundreds of billions of dollars in profits every year – want us to pay for their research and development costs, and then charge us through the nose for the new drugs they’ve developed with our own money!

Of course, they use sensationalistic scare tactics to make their point, claiming we’ll all end up dying of superbug infections if we don’t foot the bill for their research and development into new and more powerful classes of antibiotic drugs.

What About Antimicrobial Silver?

But in my previous article, I pointed out that in study after study after study after study after study after study after study it’s been demonstrated that colloidal silver and other forms of antimicrobial silver kills drug-resistant super-pathogens.

I also pointed out that studies from BYU have demonstrated that existing prescription antibiotic drugs often regain their full effectiveness against super-pathogens when colloidal silver is added to the drug regimen.

So there’s really no reason spend billions of dollars of taxpayer money on the development of new drugs, when antimicrobial silver can be used to staunch the tide of super-pathogen infections, instead.

Here It Comes…

But Big Pharma has no intention of looking into antimicrobial silver. After all, silver is a natural substance, and even if you could patent it as a drug and sell it for hundreds of dollars a prescription, people can still make and use their own antimicrobial colloidal silver for just pennies in the comfort and privacy of their own homes.

So Big Pharma ignores silver in the fight against drug-resistant infections. And now they’re forcing governments to tap into the taxpayer’s wallets for new drug development.

Indeed, according to an article in the June 19, 2012 issue of Infectious Disease News, the U.S. government has simply caved in to Big Pharma’s demands, and is now going to start paying for pharmaceutical company research into new antibiotic drugs with your tax money and mine.

Below is a brief excerpt from the article. Be sure to note how the author repeatedly uses the word “incentives” in place of the phrase “taxpayer money.” But don’t be fooled by the semantics. It’s your money they’re funneling to Big Pharma in order to give them the “incentive” to develop more antibiotic drugs:

“The United States House and Senate members have announced a bipartisan agreement on the FDA’s Safety and Innovation Act, which includes language to address antibiotic research and development and to bring new antibiotics to the country, according to an Infectious Disease Society of America statement.

IDSA has advocated for such antibiotic incentives, and hopes that the incentives spark interest in this area of medicine. Their 10 x ’20 initiative outlines the need to bring antibiotics to people who need them in the United States and abroad. They say that other incentives will be necessary to reach these goals.

Possible incentives include tax credits for research and development, public-private collaborations and the Limited Population Antibacterial Drug mechanism to streamline FDA approval, which the IDSA recently proposed.”

Translation: The U.S. government is going to provide “incentives” (read: taxpayer money) to the big drug companies as a means of “sparking their interest” in developing new antibiotic drugs. What’s more, once Big Pharma gets started, they’re going to need “other incentives” (i.e., code for massive tax breaks on their profits) in order to reach their goals. Finally, they’re also going to need “streamlined FDA approval” of these drugs by no longer requiring stringent safety testing.

Well, that’s awfully comforting, isn’t it?

We pay for their development of the drugs out of our taxes. Then Big Pharma sells the drugs back to us for massive profits. And now the drugs will be more toxic than ever. And on top of that, Big Pharma will ultimately pay no taxes on the profits they reap from these drugs. Such a deal, huh?

The Illusion of Humanitarianism

Of course, Infectious Disease News tries to make it sound like the government came up with this idea as a humanitarian means of “incentivizing” the big drug companies to work harder on developing new antibiotic drugs. But nothing could be further from the truth.

As I pointed out in my previous article, the entire scheme was concocted by Big Pharma from day one. And if you don’t believe me, perhaps you’ll believe the architects of the scheme – i.e., the Infectious Disease Society of America – who have explained in glowing and approving terms on their own web site how Big Pharma has pulled it off.

There you’ll read how 14 major drug companies backed the plan, which is called the “10x’20 Initiative” because it “aims to encourage the development of 10 new systemic antibiotics by the year 2020.” Isn’t that precious?

And of course, just as I warned, Big Pharma used sensationalistic and apocalyptic scare tactics to get the plan implemented by Congress:

“We’re on the brink of a medical catastrophe – more and more patients are succumbing to drug-resistant infections for which we have no good treatment options, and yet the number of new antibacterial drugs being developed is plummeting,” said Thomas G. Slama, MD, president of IDSA. “We are engaged in ongoing discussion with congressional leaders to help them appreciate just how serious this problem is…”

The Big Shakedown

Of course, the whole thing reeks to high heaven of an organized crime shakedown. And that’s exactly what it is.

According to the book, The Truth About the Drug Companies: How They Deceive Us and What to Do About It, by Marcia Angell, “Drug companies often decided to stop making important drugs in order to free up capacity for drugs with bigger market potential.”

In other words, it’s not that the antibiotic drugs are unprofitable to produce. They’re very profitable. It’s just that other drugs, such as heart drugs, diabetes drugs, arthritis drugs and others are even more profitable because patients have to take them for a lifetime. And the big drug companies would rather produce the most profitable drugs possible, even though it means millions of lives will be lost as a consequence of cutting back on the production of less profitable drugs like antibiotics.

But hey, don’t worry. After all, if the U.S. government will just funnel plenty of taxpayer money into the coffers of Big Pharma, the drug companies will do us a great big favor and work on developing a few more of these less profitable antibiotic drugs. But just 10 more, mind you. And then…well…we’re apparently on our own unless we keep the flow of taxpayer money (er…uh…I mean “incentives”) coming.

You know how it works: Once the taxpayers are forced by Big Brother to pick up the tab for Big Business, it never ends. They just keep demanding more. It’s called Corporate Welfare. And it’s the biggest scam in town.

Colloidal Silver to the Rescue!

Meanwhile, if you see the handwriting on the wall, you know it’s time to learn how to make and use colloidal silver with a high-quality Micro-Particle Colloidal Silver Generator from The Silver Edge.

I won’t say any more than that, because I just don’t think it’s necessary. You either get it at this point, or you don’t.

Big Pharma and their cronies in the FDA (and in Congress) are shaking down the entire population. And now that they’ve managed to tap into the taxpayer trough, the infectious disease crisis is simply going to get worse and worse.

Why? Because that’s where the money is now – a never-ending supply, compliments of the U.S. taxpayers. And the only thing Big Pharma really cares about is money. So please don’t suffer under the delusion that they’ll actually stop the so-called superbug crisis if we’ll pay them to develop new antibiotic drugs.

To Big Pharma, human life means nothing compared to billions of dollars in easy taxpayer money. But you can even-up the odds by learning how to make and use your own high-quality antimicrobial colloidal silver.

Yours for the safe, sane and responsible use of colloidal silver,
Steve Barwick Signature
Steve Barwick, author
The Ultimate Colloidal Silver Manual

Helpful Links:

FREE Colloidal Silver Safe Dosage Report
Colloidal Silver Secrets Group on Facebook
Make Your Own Colloidal Silver for Pennies
.999 Pure Silver Wire for Making Colloidal Silver
Subscribe to the Colloidal Silver Secrets Ezine
Videos on Making and Using Colloidal Silver
Real-Life Colloidal Silver Success Stories
Colloidal Silver Update (News & Views)
The Ultimate Colloidal Silver Manual
The Colloidal Silver Secrets Video
Colloidal Silver Cures MRSA
Colloidal Silver Kills Viruses
Colloidal Silver Secrets blog
Meet Steve Barwick

Important Note and Disclaimer: The contents of this Ezine have not been evaluated by the Food and Drug Administration. Information conveyed herein is from sources deemed to be accurate and reliable, but no guarantee can be made in regards to the accuracy and reliability thereof. The author, Steve Barwick, is a natural health journalist with over 30 years of experience writing professionally about natural health topics. He is not a doctor. Therefore, nothing stated in this Ezine should be construed as prescriptive in nature, nor is any part of this Ezine meant to be considered a substitute for professional medical advice. Nothing reported herein is intended to diagnose, treat, cure or prevent any disease. The author is simply reporting in journalistic fashion what he has learned during the past 17 years of journalistic research into colloidal silver and its usage. Therefore, the information and data presented should be considered for informational purposes only, and approached with caution. Readers should verify for themselves, and to their own satisfaction, from other knowledgeable sources such as their doctor, the accuracy and reliability of all reports, ideas, conclusions, comments and opinions stated herein. All important health care decisions should be made under the guidance and direction of a legitimate, knowledgeable and experienced health care professional. Readers are solely responsible for their choices. The author and publisher disclaim responsibility and/or liability for any loss or hardship that may be incurred as a result of the use or application of any information included in this Ezine.